Abstract

Chondroitin polymerization was first demonstrated in vitro when human chondroitin synthase (ChSy) was coexpressed with human chondroitin polymerizing factor (ChPF), which is homologous to ChSy but has little glycosyltransferase activity. To analyze the biological function of chondroitin, the Caenorhabditis elegans ortholog of human ChSy (sqv-5) was recently cloned, and the expression of its product was depleted by RNA-mediated interference (RNAi) and deletion mutagenesis. Blocking of chondroitin synthesis resulted in defects of cytokinesis in early embryogenesis, and eventually, cell division stopped. Here, we cloned the ortholog of human ChPF in C. elegans, PAR2.4. Despite little glycosyltransferase activity of the gene product, chondroitin polymerization was demonstrated as in the case of mammals when PAR2.4 was coexpressed with cChSy in vitro. The worm phenotypes including the reversion of cytokinesis, observed after the depletion of PAR2.4 by RNAi, were very similar to the cChSy (sqv-5)-RNAi phenotypes. Thus, PAR2.4 in addition to cChSy is indispensable for the biosynthesis of chondroitin in C. elegans, and the two cooperate to synthesize chondroitin in vivo. The expression of the PAR2.4 protein was observed in seam cells, which can act as neural stem cells in early embryonic lineages. The expression was also detected in vulva and distal tip cells of the growing gonad arms from L3 through to the young adult stage. These findings are consistent with the notion that chondroitin is involved in the organogenesis of the vulva and maturation of the gonad and also indicative of an involvement in distal tip cell migration and neural development.

Highlights

  • The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AB110823 andAB110824

  • We revealed that the enzyme complex consisting of human chondroitin synthase (ChSy) [5] and chondroitin polymerizing factor (ChPF) [6] could polymerize chondroitin chains in vitro

  • We showed that PAR2.4 is the C. elegans ortholog of human ChPF, and only two genes, PAR2.4 and sqv-5, are required for chondroitin biosynthesis

Read more

Summary

EXPERIMENTAL PROCEDURES

Strains—All the strains were obtained from the Caenorhabditis Genetics Center (Minneapolis, MN). A polymerization reaction using 100 nmol of GlcUA␤1-3Gal␤1-O-C2H4NHCbz as an acceptor was conducted in incubation mixtures containing the following in a total volume of 20 ␮l, i.e. 0.25 mM UDP-GalNAc, 0.25 mM UDP-[14C]GlcUA (1.35 ϫ 106 dpm), 100 mM MES buffer, pH 6.2, 10 mM MnCl2, and 10 ␮l of suspended beads. Transgenic Constructs—The expression vector pFX_DsRedXT or pFX_ EGFPT is composed of Bluescript (Stratagene, Palo Alto, CA) with an additional multiple cloning site followed by DsRed or enhanced GFP (EGFP) cDNA (Clontech) and about 1 kb of 3Ј-untranslated region from the unc-86 gene for poly(A) signal.. The PCR fragment was inserted into pFX_ DsRedXT using the TA cloning strategy to fuse the coding sequence region of DsRed. The sqv-5 (cChSy) reporter gene plasmid was constructed using the vector pFX_EGFPT as above. The images were processed using MetaMorph software (version 4.6, Universal Imaging)

RESULTS
HS disaccharide composition
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call